Santa Cruz Biotechnology offers a broad range of GTAM2 Marker Antibodies for advanced research in cellular biology. GTAM2 Marker Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GTAM2, or GTPase-activating protein for the Rho family, plays a crucial role in regulating cellular signaling pathways, influencing processes such as cell migration, proliferation, and differentiation. GTAM2 significantly impacts various physiological and pathological conditions, making it a key target for understanding diseases, including cancer and neurodegenerative disorders. Researchers can explore GTAM2's role in cell signaling cascades and its impact on cellular behavior. Advanced visualization techniques allow scientists to track GTAM2 localization and interactions within cellular compartments. Understanding GTAM2's regulatory mechanisms provides valuable insights into potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic approaches.